Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hanoi Halts Hepatitis B Vaccinations After Baby’s Death (Vietnam)

This article was originally published in PharmAsia News

Executive Summary

Health centers in Vietnam's capital were ordered to stop using hepatitis B vaccines because a baby died after being inoculated with it. Hanoi's Preventive Health Center also urged hospitals and other health facilities to stop giving the vaccine, which is given to babies for free under the country's National Inoculation Program. The cause of the baby's death was unknown, but doctors said it died six hours after an injection with the recombinant DNA vaccine Euvax-B, made by South Korea-based LG Life Sciences. (Click here for more

Health centers in Vietnam's capital were ordered to stop using hepatitis B vaccines because a baby died after being inoculated with it. Hanoi's Preventive Health Center also urged hospitals and other health facilities to stop giving the vaccine, which is given to babies for free under the country's National Inoculation Program. The cause of the baby's death was unknown, but doctors said it died six hours after an injection with the recombinant DNA vaccine Euvax-B , made by South Korea-based LG Life Sciences. (Click here for more )

"Hanoi Halts All Hepatitis B Vaccines Following Baby's Death" Thanhnien (Vietnam) (1/8/08)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066574

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel